CD8 T-Cells in CMV Infection
Author Information
Author(s): Miles David J. C., van der Sande Marianne, Jeffries David, Kaye Steve, Ojuola Olubukola, Sanneh Mariama, Cox Momodou, Palmero Melba S., Touray Ebrima S., Waight Pauline, Rowland-Jones Sarah, Whittle Hilton, Marchant Arnaud
Primary Institution: MRC Laboratories Gambia
Hypothesis
Do differentiated CD8 T-cell subpopulations persist in Gambian infants two years after cytomegalovirus (CMV) infection?
Conclusion
The large differentiated subpopulations of CD8 T-cells that emerged after CMV infection persisted through the second year post-infection.
Supporting Evidence
- CMV-specific CD8 T-cells remained more activated and differentiated than the overall CD8 T-cell population.
- The infection rate among infants rose to 96% by 24 months of age.
- The large sizes of peptide-specific clones indicated that CMV continued to be a major determinant of the CD8 T-cell population.
Takeaway
This study found that special immune cells called CD8 T-cells stay strong and ready to fight CMV infections in babies for a long time, even after two years.
Methodology
The study involved monitoring Gambian infants for CMV infection and analyzing their CD8 T-cell responses over two years.
Potential Biases
Recruitment of the subcohort was biased towards infants whose CD8 T-cells bound available tetramers.
Limitations
The study was limited by the small number of uninfected infants available for comparison at 24 months.
Participant Demographics
Gambian infants, primarily healthy singletons with a birth weight of at least 1.95 kg.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website